A searchable database of
medically documented cases

About the Project

Leukemia

Leukemia

Epidemiology:

Leukemia ranks among the most prevalent and impactful hematologic malignancies worldwide, with an estimated incidence of approximately 1,343,850 cases reported globally in 20191. In the United States, the annual incidence of leukemia is around 61,780 new cases, with approximately 22,840 fatalities, underscoring its significant public health burden2. Despite advances in treatments, leukemia continues to represent a leading cause of cancer-related death, reflective of its complex pathophysiology and the challenges associated with effective management3. Spontaneous remission (SR) in leukemia is exceptionally rare, occurring in fewer than 1% of diagnosed cases, with such instances often characterized by their dramatic and sustained nature, complicating efforts to accurately assess their true prevalence due to underreporting or transient remission episodes.4,5

Clinical Characteristics:

A total of 110 well-documented cases of SR in leukemia have been reported between 1949 and 2025. The ages of affected individuals ranged from newborn to 88 years (mean ≈ 53 years), with a near-equal male-to-female ratio of approximately 1.1:1 and a peak incidence in the 50–70-year age group. Overall, SR tended to occur in older adults and occasionally in infants with congenital leukemia, with remission most often observed in systemic disease rather than localized forms. See table 1 below for further information.

Histological Characteristics:

Patients who experienced spontaneous remission of leukemia typically presented with hematologic abnormalities such as leukocytosis, cytopenia, or organomegaly, and the diagnosis was confirmed through peripheral blood and bone marrow examinations showing leukemic cell infiltration. Most cases involved advanced or systemic disease, with the bone marrow and peripheral blood being the predominant primary sites, and occasional extramedullary involvement of the skin, lymph nodes, liver, or spleen. Remission was verified by normalizing hematologic parameters and bone marrow findings demonstrating leukemic cells' disappearance or marked reduction. Nearly all SR cases were associated with durable hematologic recovery or long-term disease stability, substantially exceeding the expected prognosis for untreated leukemia.

Proposed Contributing Mechanisms:

Various mechanisms have been proposed to explain spontaneous remission in leukemia. The most frequently reported involve infection-induced immune activation, often following bacterial or viral illness, sepsis, or febrile episodes. Additional contributing factors included transfusion-related immune responses, T-lymphocytic hyperplasia, endogenous interferon activity, and hormonal or postpartum immune modulation. A few cases further described apoptotic or differentiation-related processes, such as Fas-mediated cell death or marrow recovery responses.

Site and Extent of Remission:

The bone marrow and peripheral blood were the predominant sites of both disease involvement and remission in the majority of reported leukemia SR cases. Extramedullary remissions were occasionally described, affecting the skin, lymph nodes, liver, spleen, or, rarely, the eye. In several patients, remission encompassed both medullary and extramedullary compartments, indicating systemic resolution rather than localized regression. The duration of remission varied widely, from weeks to several years, with a substantial proportion of patients achieving long-term hematologic stability or sustained remission without relapse.

Table 1: Leukemia SR Cases and Clinical Characteristics

Author–year

Age/sex

Primary site

Remission site

Proposed mechanisms

Follow-up

Birge et al., 19496

33/F

Blood, bone marrow

Blood, bone marrow

Postpartum immune recovery

21 months

Pelner et al., 19587

Not reported (350 patients, mixed group)

Blood

Blood

Infection-induced immune response

Not reported

Ngu, 19678

4/M

Maxillae, mandibles, left cheek, right eyelid

Jaw and facial tumors

Passive immune transfer

3 months

Chervenick et al., 19679

63/M

Blood

Blood

Not reported

11 years

Nagao et al., 197010

Newborn/M

Bone marrow

Blood, bone marrow

Not reported

Not reported

Wiernik, 197611

Not reported

Blood, bone marrow

Blood, bone marrow

Bacterial or viral infection

Weeks to years

Lebedev et al., 197612

Three males

Blood, bone marrow

Blood, bone marrow

Not reported

6–10 years

Lebedev et al., 197612

37/F

Abdominal lymph nodes

Blood, bone marrow, lymph nodes

Not reported

5 years

Hansen & Libnoch, 197813

78/M

Blood, bone marrow

Bone marrow, lymph nodes

Immune stimulation

3 years

Lachant et al., 197914

67/F

Bone marrow

Lung, bone marrow

Infection-induced immune activation

19 months

Long et al., 197915

7/F

Bone marrow

Blood and bone marrow

Not reported

4.5 months

Ragni & Shreiner, 198116

Two Males

Bone marrow

Bone marrow

Not reported

22 and 16 months

Hughes et al., 198117

58/M

Bone marrow

Bone marrow

Not reported

>2 years

Kimura et al., 198318

36/M

Peripheral blood

Skin, lungs

Infection-induced immune activation

4 years

Silingardi et al., 198519

53/M

Bone marrow

Liver, spleen, bone marrow

Infection-induced immune activation

17 years

Smadja et al., 198620

27/M

Bone marrow

Bone marrow

Not reported

8 years

Ribera et al., 198721

49/F

Bone marrow

Lymph nodes, spleen, Waldeyer’s ring

Infection-induced immune activation

Not reported

Ribera et al., 198721

57/F

Bone marrow

Lymph nodes, spleen, bone marrow

Not reported

Not reported

Deharo et al., 198722

Not reported

Blood

Blood

Infection-induced immune activation

Not reported

Gottesfeld et al., 198923

Newborn/M

Bone marrow

Skin

Not reported

26 months

Grundy et al., 200024

Newborn/M

Skin (congenital leukemia cutis)

Skin

Not reported

26 months

Jeha et al., 200025

12/M

Bone marrow, blood

Bone marrow, blood

G-CSF withdrawal

6 months

Martelli et al., 200026

26/F

Bone marrow

Bone marrow

Infection-induced immune response

25 months

Mora et al., 200027

Newborn/F (twin A)

Skin

Skin, Bone marrow

Self-limited leukemic clone

Not reported

Mora et al., 200027

Newborn/F (twin B)

Skin

Skin, Bone marrow

Self-limited leukemic clone

Not reported

Muraki et al., 200028

88/F

Bone marrow

Bone marrow, blood

Fas-mediated apoptosis

Not reported

Upshaw et al., 200229

83/M

Bone marrow

Bone marrow, blood

T-lymphocyte activation or hyperplasia

8 years

Thomas et al., 200230

60/F

Bone marrow

Blood and lymph nodes

Natural regulatory mechanism

Not reported

Thomas et al., 200230

69/M

Bone marrow

Blood, Bone Marrow, lymph nodes

Natural regulatory mechanism

Not reported

Thomas et al., 200230

70/F

Bone marrow

Blood, bone marrow

Natural regulatory mechanism

10 years

Thomas et al., 200230

51/F

Bone marrow

Blood and lymph nodes

Natural regulatory mechanism

6 years

Thomas et al., 200230

54/M

Bone marrow

Blood and lymph nodes

Natural regulatory mechanism

7 years

Thomas et al., 200230

73/F

Bone marrow

Blood, bone marrow

Natural regulatory mechanism

11 years

Thomas et al., 200230

69/F

Bone marrow

Blood, spleen, and bone marrow

Natural regulatory mechanism

4 years

Thomas et al., 200230

57/M

Bone marrow

Blood, spleen, and bone marrow

Natural regulatory mechanism

13 years

Thomas et al., 200230

47/M

Bone marrow

Blood, lymph nodes, and spleen

Natural regulatory mechanism

18 years

Sosin & Handa, 200331

82/M

Blood

Blood

Infection-related immune activation

18 months

Kazakov et al., 200332

79/M

Skin

Skin

Not reported

18 months

Maywald et al., 200333

31/M

Bone marrow

Bone marrow

Infection-induced immune response

2 months

Morris, 200334

74/F

Bone marrow

Bone marrow, blood

T-lymphocytic hyperplasia

Not reported

Bassan et al., 200335

61–67/Maj F

Spleen

Blood, spleen

Cytokine suppression, immune modulation

15 years

Fozza et al., 200436

72/M

Bone marrow, blood

Bone marrow, blood

Cross-activated immune response

5 months

Müller et al., 200437

61/M

Bone marrow

Bone marrow, blood

Infection-induced immune response

29 months

Shichishima et al., 200438

69/M

Bone marrow

Bone marrow, blood

Cellular phenotype abnormality

39 months

Shichishima et al., 200438

46/M

Bone marrow

Bone marrow, blood

Cellular phenotype or immune modulation

7 years

Lander et al., 200539

Newborn/M

Skin, bone marrow

Skin

Not reported

8 months

Sonneck et al., 200540

56/F

Bone marrow

Bone marrow, blood

Transfusion-related immune response

Not reported

Tsavaris et al., 200641

64/M

Bone marrow

Bone marrow, blood

Hormonal modulation via GnRH agonist

4 years

Daccache et al., 200742

83/F

Bone marrow, blood

Bone marrow, blood

Immune response

2.5 months

Jankipersadsing et al., 200743

49/F

Lungs

Pulmonary infiltrates (lungs)

Not reported

1 year

Trof et al., 200744

29/M

Bone marrow

Blood, bone marrow

Sepsis-induced cytokines

6 months

Trof et al., 200744

28/M

Bone marrow

Blood, bone marrow

Sepsis-induced cytokines

1 month

Yoruk et al., 200845

4/F

Blood

Bone marrow, mediastinal mass

Infection-induced immune activation

Not reported

Kanegane et al., 200946

6 months/M

Skin

Skin, bone marrow

Not reported

1 year

Marisavlievic et al., 200947

63/M

Bone marrow

Bone marrow

Transfusion-related immune response

7 years

Bernardeschi & Pirrotta, 201048

40/F (pregnant)

Blood

Blood

Elevated interferon levels during pregnancy

Not reported

Teng et al., 201149

75/M

Bone marrow

Bone marrow, blood

Infection-induced immune activation

21 weeks

Wu et al., 201150

Newborn/F

Skin and bone marrow

Skin and bone marrow

Not reported

11 months

Alsultan et al., 201251

29 months/M

Blood, bone marrow

Blood, bone marrow

Not reported

>2 years

Boonchalermyichian et al., 201252

50/F

Bone marrow, blood

Bone marrow, blood

Immune response

5 months

Elhasid et al., 201253

9 months/M

Bone marrow

Bone marrow

Immune activation

4 months

Herishanu et al., 201254

54/M

Lymph nodes

Lymph nodes, bone marrow

Cancer immune surveillance

3 years

Xie et al., 201255

42/M

Bone marrow and blood

Bone marrow and blood

Cytokine-mediated immune response

2 Years

Zeng et al., 201356

31/M

Bone marrow, lung

Bone marrow

Immune response to infection

Not reported

Zeng et al., 201356

34/F

Bone marrow, skin

Bone marrow

Immune response to infection

Not reported

Nakhla et al., 201357

70/M

Blood

Blood

Not reported

5 months

Adam & Eltayeb, 201458

35/M

Blood, bone marrow

Bone marrow

Immune response, blood transfusion

6 weeks

Yasuda et al., 201459

67/M

Skin, stomach

Skin lesions

Not reported

Not reported

Purohit et al., 201560

46/M

Blood, bone marrow

Blood, bone marrow

Not reported

Not reported

Kumar et al., 201561

7/M

Bone marrow, blood

Bone marrow, blood

Parvovirus B19–induced cytotoxicity

4 years

Vachhani et al., 201662

73/F

Blood, bone marrow

Bone marrow

Innate host immune responses

Not reported

Jesudas et al., 201763

2months/F

Skin, bone marrow

Skin, bone marrow

Not reported

6 weeks

Barrett et al., 201764

Infant/F

Skin, bone marrow

Skin, bone marrow

Not reported

5 months

Mozafari et al., 201765

53/M

Bone marrow, blood

Bone marrow

Immune activation

Not reported

Ikawa et al., 201866

Newborn/F

Bone marrow

Bone marrow

Congenital AML, chromosome 8 translocation

3 months

Höres et al., 201867

31/F

Blood

Blood

Infection-induced cytokine immune response

6 weeks

Iqbal et al., 201868

15 months/F

Bone marrow

Bone marrow

Infection-induced cytokine immune response

173 days

Hoshino et al., 201869

49/F

Bone marrow

Bone marrow

Not reported

4 months

Grunwald et al., 201970

72/M

Bone marrow

Bone marrow, skin

Not reported

Not reported

Suyama et al., 201971

67/M

Bone marrow

Bone marrow

Immune response

Not reported

Rautenberg et al., 201972

42/F

Bone marrow

Bone marrow

Infection-induced immune response

Not reported

Suzuki et al., 201973

47/F

Blood

Skin

Cytotoxic response

Not reported

Bradley et al., 202074

58/M

Bone marrow

Bone marrow

Marrow stress response

Not reported

Kubo et al., 202075

36 days/F

Bone marrow

Bone marrow

Not reported

Not reported

Martínez-Díez et al., 202276

71/M

Blood

Bone marrow

Infection-induced immune activation

Not reported

Bülbül et al., 202277

67/M

Blood

Bone marrow

Cytokine-induced antitumor immunity

5 months

Barkhordar et al., 202278

57/F

Bone marrow

Bone marrow

Infection-induced immune response

6 months

Alshurafa et al., 202379

56/M

Blood

Bone marrow

Not reported

5 months

Imataki et al., 202380

80/F

Blood

Bone marrow

Infection-induced immune activation

15 months

McCormick et al., 202481

3/F

Bone marrow

Bone marrow

Sepsis-induced cytokines

Not reported

Diral et al., 202482

65/F

Bone marrow

Eye (choroid)

Not reported

1 year

Peñuela et al., 202483

25/F

Blood

Bone marrow

Immune response

5 months

Higaki-Mori et al., 202584

47/M

Skin

Skin

Not reported

Not reported

Southam et al., 195185

Infection-related, adrenal stress

Al-Tawfiq, 200786

Infection Related Remission

Hudecek et al., 200787

35/F

Blood

Blood

Immune recovery

Persistent CR after relapse

Thomas, 200988

60/M

Blood vessels

Lung lesions

none

9 months

D'Arena et al., 201489

57/F

Blood

Immune response

D'Arena et al., 201489

75/F

Blood

Blood

Immune response

Kazmierczak et al., 201490

77/M

Blood

Blood

Graft versus host disease and graft-versus leukemia

Complete hematological remission by November 2011

Gyarfas et al., 201691

14 months/F

Bone marrow, oral mucosa, skin

Bone marrow

Cytokine release

Complete clinical improvement

Gomez et al., 200292

64/M

Bone marrow

Bone marrow

42 months

Muller-Schmah et al., 201293

61/M

Bone marrow

Peripheral blood

Immune response

Shichishima et al., 200094

69/M

Bone marrow

Bone marrow

Unusual cell features

2 years

Van et al., 200495

3.5/F

Skin

Soles of both feet

Immune response, low tumor burden

Well at 3.5 years

Wajima, 200096

77/M

Bone marrow

Altered host-tumor relationship

3 years

Helbid, 202097

40/M

Bone marrow

Bone marrow

Immune-mediated

Raza et al., 198598

Bone marrow

Immune system stimulation

Schnitzer et al., 835799

73/M

Spontaneous remission

Han, 1987100

37-69/M:7, F:4

Viral infection

5 alive, 2 died unrelated

Hackett & Hallidie-Smith et al., 1984101

1/F

Chan et al., 1989102

7w/F

Normal heart at 8 weeks

Labbe et al., 1983103

3/F

2 years

Weintraub et al., 2000104

7 days/F

Bone marrow

Skin and bone marrow

Not reported

15 months

References:

  1. Zhang, N., Wu, J., Wang, Q., Liang, Y., Li, X., Chen, P., … & Zhou, F. (2023). Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer Journal, 13(1). https://doi.org/10.1038/s41408-023-00853-3
  2. Hao, T., Li-Talley, M., Buck, A., & Chen, W. (2019). An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-48445-1
  3. Yıldız, A., Albayrak, M., Pala, Ç., Öztürk, H., Maral, S., Şahin, O., … & Cömert, P. (2019). The incidence and risk factors of thrombosis and the need for thromboprophylaxis in lymphoma and leukemia patients: a 9-year single-center experience. Journal of Oncology Pharmacy Practice, 26(2), 386-396. https://doi.org/10.1177/1078155219851540
  4. Zhang, J., Yan, Z., Sun, X., Liu, Y., Yin, Y., Su, M., … & Li, D. (2024). Association between serum lactate dehydrogenase level and 30-day mortality in patients with intracranial hemorrhage with acute leukemia in the induction phase: a cohort study. Global Medical Genetics, 11(02), 142-149. https://doi.org/10.1055/s-0044-1786005
  5. Seo, S., Lee, D., Jin, Y., Lee, W., & Park, S. (2018). Usefulness of cancer-free survival in estimating the lifetime attributable risk of cancer incidence from radiation exposure. Journal of Radiological Protection, 38(3), N17-N24. https://doi.org/10.1088/1361-6498/aac3f3
  6. Birge RF, Jenks AL Jr, Davis SK. Spontaneous remission in acute leukemia; report of a case complicated by eclampsia. JAMA. 1949;140(7):589–592.
  7. Pelner L, Fowler GA, Nauts HC. Effects of concurrent infections and their toxins on the course of leukemia. Acta Med Scand Suppl. 1958;162(Suppl 338):1–47.
  8. Ngu VA. Host defences to Burkitt tumour. Br Med J. 1967;1(5536):345-347. doi:10.1136/bmj.1.5536.345
  9. Chervenick PA, Boggs DR, Wintrobe MM. Spontaneous remission in chronic lymphocytic leukemia. Ann Intern Med. 1967;67(6):1239–1242.
  10. Nagao T, Lampkin BC, Hug G. A neonate with Down’s syndrome and transient abnormal myelopoiesis: serial blood and bone marrow studies. Blood. 1970;36(4):443–447.
  11. Wiernik PH. Spontaneous regression of hematologic cancers. Natl Cancer Inst Monogr. 1976;44:35–38.
  12. Lebedev VN, Kosukhina NV, Lebedeva YL. Spontaneous remission in chronic lymphoid leukemia. Ter Arkh. 1976;48(8):26–30.
  13. Hansen RM, Libnoch JA. Remission of chronic lymphocytic leukemia after smallpox vaccination. Arch Intern Med. 1978;138:1137–1138.
  14. Lachant NA, Goldberg J, Nelson DA, Gottlieb AJ. Spontaneous remission in acute myelogenous leukemia in the adult. Am J Med. 1979;67(4):687–692.
  15. Long K, Egan EL. Spontaneous remission in acute lymphocytic leukaemia: case report. J Ir Med Assoc. 1979;72(8):335–337.
  16. Ragni MV, Shreiner DP. Spontaneous remission of agnogenic myeloid metaplasia and termination in acute myeloid leukemia. Arch Intern Med. 1981;141(11):1481–1484.
  17. Hughes RG, Islam A, Lewis SM, Catovsky D. Spontaneous remission following bone marrow necrosis in chronic lymphocytic leukaemia. Clin Lab Haematol. 1981;3(2):173–183.
  18. Kimura I, Tsubota T, Hayashi K, Ohnoshi T. Spontaneous complete remission in adult T-cell leukemia: a case report. Jpn J Clin Oncol. 1983;13(Suppl 2):231–236.
  19. Silingardi V, Federico M, Barbieri F, Artusi T, Mauri C. Hairy cell leukemia: a reversible disease? A report of two cases of spontaneous remission. Haematologica. 1985;70(5):437–441.
  20. Smadja N, Krulik M, Audébert AA, Degramont A, Debray J. Spontaneous regression of cytogenetic and hematologic anomalies in Ph1 positive chronic myelogenous leukaemia. Br J Haematol. 1986;63(2):257–262.
  21. Ribera JM, Viñolas N, Urbano-Ispizua A, Gallart T, Montserrat E, Rozman C. “Spontaneous” complete remissions in chronic lymphocytic leukemia: report of three cases and review of the literature. Blood Cells. 1987;12:471–479.
  22. Deharo S, Bizet M, Monconduit M, Tilly H, Sari F, Piguet H. Spontaneous remission of refractory anemia with excess of blasts after septicemia. Ann Med Interne (Paris). 1987;138(8):663–664.
  23. Gottesfeld E, Silverman RA, Coccia PF, Jacobs G, Zaim MT. Transient blueberry muffin appearance of a newborn with congenital monoblastic leukemia. J Am Acad Dermatol. 1989;21(2 Pt 2):347–351.
  24. Grundy RG, Martinez A, Kempski H, Malone M, Atherighton D. Spontaneous remission of congenital leukemia: a case for conservative treatment. J Pediatr Hematol Oncol. 2000;22(3):252-255. doi:10.1097/00043426-200005000-00011
  25. Jeha S, Chan KW, Aprikyan AG, Hoots WK, Culbert S, Zietz H, Dale DC, Albitar M. Spontaneous remission of granulocyte colony-stimulating factor–associated leukemia in a child with severe congenital neutropenia. Blood. 2000;96(10):3647–3649.
  26. Martelli MP, Latagliata R, Spadea A, Avvisati G, Mancini M, Romano A, Luzi G, Petti MC. Molecular and cytogenetic remission in a case of subtype M4E acute myelogenous leukemia with minimal chemotherapy: high sensitivity or spontaneous remission? Eur J Haematol. 2000;65(3):203-206. doi:10.1034/j.1600-0609.2000.9c220.x
  27. Mora J, Dobrenis AM, Bussel JB, Aledo A. Spontaneous remission of congenital acute nonlymphoblastic leukemia with normal karyotype in twins. Med Pediatr Oncol. 2000;35(2):110-113. doi:10.1002/1096-911x(200008)35:2<;110::aid-mpo4>3.0.co;2-z
  28. Muraki K, Shinohara K, Takahashi T, Ota I, Nawata R. Case of adult T-cell leukemia resulting in spontaneous remission and pancytopenia. Am J Hematol. 2000;65(4):325-326. doi:10.1002/1096-8652(200012)65:4<;325::aid-ajh16>3.0.co;2-u
  29. Upshaw JD Jr, Callihan TR. Spontaneous remission of B-cell chronic lymphocytic leukemia associated with T lymphocytic hyperplasia in bone marrow. South Med J. 2002;95(6):647-649.
  30. Thomas R, Ribeiro I, Shepherd P, Johnson P, Cook M, Lakhani A, Kaczmarski R, Carrington P, Catovsky D. Spontaneous clinical regression in chronic lymphocytic leukaemia. Br J Haematol. 2002;116(2):341–345. doi:10.1046/j.1365-2141.2002.03286.x
  31. Sosin MD, Handa SI. Spontaneous remission of large granular lymphocytic leukaemia. Int J Clin Pract. 2003;57(6):551-552.
  32. Kazakov DV, Belousova IE, Michaelis S, Palmedo G, Samtsov AV, Kempf W. Unusual manifestation of specific cutaneous involvement by B-cell chronic lymphocytic leukemia: spontaneous regression with scar formation. Dermatology. 2003;207(1):111-115. doi:10.1159/000070961
  33. Maywald O, Buchheidt D, Bergmann J, Schoch C, Ludwig WD, Reiter A, Hastka J, Lengfelder E, Hehlmann R. Spontaneous remission in adult acute myeloid leukemia in association with systemic bacterial infection: case report and review of the literature. Ann Hematol. 2004;83(3):189-194. doi:10.1007/s00277-003-0741-y
  34. Morris DJ. Spontaneous remission of B-cell chronic lymphocytic leukemia associated with T lymphocytic hyperplasia in bone marrow. South Med J. 2003;96(3):324. doi:10.1097/01.SMJ.0000061507.81880.04
  35. Bassan R, Spinelli O, Rambaldi A, Barbui T. The course of monoclonal “villous” lymphocytosis over 15 years of follow-up: progression to SLVL or spontaneous clinical but not molecular remission. Leukemia. 2003;17(11):2243–2244. doi:10.1038/sj.leu.2403127
  36. Fozza C, Bellizzi S, Bonfigli S, Campus PM, Dore F, Longinotti M. Cytogenetic and hematological spontaneous remission in a case of acute myelogenous leukemia. Eur J Haematol. 2004;73(3):219–222. doi:10.1111/j.1600-0609.2004.00281.x
  37. Müller CI, Trepel M, Kunzmann R, Lais A, Engelhardt R, Lübbert M. Hematologic and molecular spontaneous remission following sepsis in acute monoblastic leukemia with translocation (9;11): a case report and review of the literature. Eur J Haematol. 2004;73(1):62-66. doi:10.1111/j.1600-0609.2004.00248.x
  38. Shichishima T, Kawaguchi M, Ono N, Oshimi K, Nakamura N, Maruyama Y. Gammadelta T-cell large granular lymphocyte (LGL) leukemia with spontaneous remission. Am J Hematol. 2004;75(3):168-172. doi:10.1002/ajh.10480
  39. Lander MC, Malempati S, Tilford D, Gatter K, White C, Schroeder TL. Spontaneous regression of aleukemic congenital leukemia cutis. Pediatr Dermatol. 2005;22(1):26-30. doi:10.1111/j.1525-1470.2005.22106.x
  40. Sonneck K, Mannhalter C, Krauth MT, et al. An unusual case of myelodysplastic syndrome with prolonged clonal stability, indolent clinical course over a decade, and spontaneous regression of acute myeloid leukemia in the terminal phase. Eur J Haematol. 2005;75(1):73-77. doi:10.1111/j.1600-0609.2005.00423.x
  41. Tsavaris N, Kopterides P, Kosmas C, Siakantaris M, Patsouris E, Pangalis G. Spontaneous remission of acute myeloid leukemia associated with GnRH agonist treatment. Leuk Lymphoma. 2006;47(3):557-560. doi:10.1080/10428190500343126
  42. Daccache A, Kizhakekuttu T, Siebert J, Veeder M. Hematologic and cytogenetic spontaneous remission in acute monocytic leukemia (FAB M5b) with trisomy 8. J Clin Oncol. 2007;25(3):344–346. doi:10.1200/JCO.2006.08.8500
  43. Jankipersadsing V, Tauchi T, Ohyashiki K, Tanaka Y, Setoguchi Y, Mukai K. Spontaneous regression of pulmonary infiltration of adult T-cell leukemia/lymphoma. Int J Hematol. 2007;86(3):207. doi:10.1532/IJH97.07044
  44. Trof RJ, Beishuizen A, Wondergem MJ, Strack van Schijndel RJ. Spontaneous remission of acute myeloid leukaemia after recovery from sepsis. Neth J Med. 2007;65(7):259–262.
  45. Yoruk A, Erguven M, Celiker E, Aki H, Timur C, Yuksel E, Ozkan H. Spontaneous remission of acute lymphoblastic leukemia with mediastinal mass. Pediatr Hematol Oncol. 2008;25(3):181–186. doi:10.1080/08880010801938132
  46. Kanegane H, Nomura K, Abe A, Makino T, Ishizawa S, Shimizu T, Naoe T, Miyawaki T. Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastocytosis. Int J Hematol. 2009;89(1):86–90. doi:10.1007/s12185-008-0216-y
  47. Marisavljevic D, Markovic O, Zivkovic R. An unusual case of smoldering acute myeloid leukemia with prolonged indolent clinical course and spontaneous remission in the terminal phase. Med Oncol. 2009;26(4):476-479. doi:10.1007/s12032-008-9153-0
  48. Bernardeschi P, Pirrotta MT. Spontaneous regression of chronic myeloid leukemia during pregnancy. Acta Haematol. 2010;124(4):225–226. doi:10.1159/000321495
  49. Teng CJ, Yang CF, Gau JP, et al. Spontaneous remission in acute myelogenous leukemia evidenced by cytogenetic changes. Ann Hematol. 2011;90(8):981-983. doi:10.1007/s00277-010-1120-0
  50. Wu X, Sulavik D, Roulston D, Lim MS. Spontaneous remission of congenital acute myeloid leukemia with t(8;16)(p11;13). Pediatr Blood Cancer. 2011;56(2):331-332. doi:10.1002/pbc.22859
  51. Alsultan A, Khalifah M, Alrabiaah AA. Spontaneous remission of juvenile myelomonocytic leukemia with NRAS mutation. Pediatr Hematol Oncol. 2012;29(7):624–626. doi:10.3109/08880018.2012.710299
  52. Boonchalermyichian R, et al. Spontaneous, transient regression of B lymphoblastic leukemia in an adult patient: a variant presentation of prodromal/pre-ALL. Pediatr Hematol Oncol. 2012;29(7):624–626. doi:10.3109/08880018.2012.710299
  53. Elhasid R, Tohami T, Moustafa-Hawash N, Ben-Ezra J, Izraeli S, Sayar D. Spontaneous remission of childhood acute marrow fibrosis and megakaryoblastic leukemia. J Pediatr Hematol Oncol. 2012;34(7):565–568. doi:10.1097/MPH.0b013e318257a172
  54. Herishanu Y, Solar I, Ben-Ezra J, Cipok M, Meirsdorf S, Amariglio N, Hoffman S, Kay S, Aharon Z, Perry C, Polliack A, Naparstek E. Complete spontaneous regression of chronic lymphocytic leukemia. J Clin Oncol. 2012;30(26):e254–e256. doi:10.1200/JCO.2011.40.7536
  55. Xie W, Zhao Y, Cao L, Huang W, Wang Y, Huang H. Cutaneous blastic plasmacytoid dendritic cell neoplasm occurring after spontaneous remission of acute myeloid leukemia: a case report and review of literature. Med Oncol. 2012;29(4):2417-2422. doi:10.1007/s12032-012-0215-y
  56. Zeng Q, Yuan Y, Li P, Chen T. Spontaneous remission in patients with acute myeloid leukemia with t(8;21) or cutaneous myeloid sarcoma: two case reports and a review of the literature. Intern Med. 2013;52(11):1227–1233. doi:10.2169/internalmedicine.52.9505
  57. Nakhla PS, Butera JN, Treaba DO, Castillo JJ, Quesenberry PJ. Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype. Leuk Lymphoma. 2013;54(8):1647–1651. doi:10.3109/10428194.2012.753449
  58. Adam M, Eltayeb A. Spontaneous remission in acute myeloid leukemia: a case report. Gulf J Oncol. 2014;1(15):84–86.
  59. Yasuda H, Takaku T, Tomomatsu J, Hosone M, Tanaka H, Komatsu N. Spontaneous regression of cutaneous blastic plasmacytoid dendritic cell neoplasm followed by acute monocytic leukemia evolving from myelodysplastic syndrome. Intern Med. 2014;53(23):2717–2720. doi:10.2169/internalmedicine.53.2740
  60. Purohit A, Aggarwal M, Kumar S, Seth T, Mishra P, Mahapatra M, Saxena R, Sharma R, Singh PK, Venkateshan S. Spontaneous remission of adult acute lymphoblastic leukemia: a very rare event. Indian J Hematol Blood Transfus. 2015;31(1):159–160. doi:10.1007/s12288-014-0351-y
  61. Kumar A, Moulik NR, Kishore J, Kumar A, Jain A. Prolonged remission in a child with chronic myeloid leukemia following Parvovirus B19 (B19V) infection. Indian J Med Microbiol. 2015;33(3):432–434. doi:10.4103/0255-0857.158580
  62. Vachhani P, Mendler JH, Evans A, Deeb G, Starostik P, Wallace PK, Wang ES. Spontaneous remission in an older patient with relapsed FLT3 ITD mutant acute myeloid leukemia. Case Rep Hematol. 2016;2016:1259759. doi:10.1155/2016/1259759
  63. Jesudas R, Buck SA, Savasan S. Spontaneous remission of congenital acute myeloid leukemia with skin involvement and t(1;11)(p32;q23). Pediatr Blood Cancer. 2017;64(3):e26269. doi:10.1002/pbc.26269
  64. Barrett R, Morash B, Roback D, Pambrun C, Marfleet L, Ketterling RP, Harrison K, Berman JN. FISH identifies a KAT6A/CREBBP fusion caused by a cryptic insertional t(8;16) in a case of spontaneously remitting congenital acute myeloid leukemia with a normal karyotype. Pediatr Blood Cancer. 2017;64(5):e26450. doi:10.1002/pbc.26450
  65. Mozafari R, Moeinian M, Asadollahi-Amin A. Spontaneous complete remission in a patient with acute myeloid leukemia and severe sepsis. Case Rep Hematol. 2017;2017:9593750. doi:10.1155/2017/9593750
  66. Ikawa Y, Nishimura R, Maeba H, Fujiki T, Kuroda R, Noguchi K, Fukuda M, et al. Deep spontaneous molecular remission in a patient with congenital acute myeloid leukemia expressing a novel MOZ-p300 fusion transcript. Leuk Lymphoma. 2018;59(10):2497–2499. doi:10.1080/10428194.2018.1434885
  67. Höres T, Wendelin K, Schaefer-Eckart K. Spontaneous remission of acute lymphoblastic leukemia: a case report. Oncol Lett. 2018;15(1):115–120. doi:10.3892/ol.2017.7288
  68. Iqbal A, Weinstein J, Angelova V, Dighe D, Giordano L. A rare case of spontaneous remission of terminal deoxynucleotidyl transferase negative B-acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2018;40(3):e176–e178. doi:10.1097/MPH.0000000000000906
  69. Hoshino T, Taki T, Takada S, Hatsumi N, Sakura T. Spontaneous remission of adult acute myeloid leukemia with t(8;16)(p11;p13)/MOZ-CBP fusion. Leuk Lymphoma. 2018;59(1):253–255. doi:10.1080/10428194.2017.1320712
  70. Grunwald VV, Hentrich M, Schiel X, et al. Patients with spontaneous remission of high-risk MDS and AML show persistent preleukemic clonal hematopoiesis. Blood Adv. 2019;3(18):2696–2699. doi:10.1182/bloodadvances.2019000265
  71. Suyama T, Hasebe K. Spontaneous remission of acute monocytic leukemia with trisomy 8 and trisomy 18. J Clin Exp Hematop. 2019;59(2):96–97. doi:10.3960/jslrt.19005
  72. Rautenberg C, Kaivers J, Germing U, Haas R, Schroeder T, Kobbe G. Spontaneous remission in a patient with very late relapse of acute myeloid leukemia 17 years after allogeneic blood stem cell transplantation. Eur J Haematol. 2019;103(2):131–133. doi:10.1111/ejh.13245
  73. Suzuki C, Hirai I, Nomura H, Ouchi T, Okayama M, Okamoto S, Amagai M, Tanese K, Takahashi H. Gamma-delta T cell large granular lymphocyte leukaemia with multiple cutaneous nodules that showed spontaneous regression. J Eur Acad Dermatol Venereol. 2019;33(3):e134–e137. doi:10.1111/jdv.15341
  74. Bradley T, Zuquello RA, Aguirre LE, et al. Spontaneous remission of acute myeloid leukemia with NF1 alteration. Leuk Res Rep. 2020;13:100204. doi:10.1016/j.lrr.2020.100204
  75. Kubo N, Iwabuchi H, Imamura M, Saitoh A, Imai C. Spontaneous remission of infant acute myeloid leukemia with a novel four-way translocation. Pediatr Blood Cancer. 2020;67(2):e28052. doi:10.1002/pbc.28052
  76. Martínez-Díez Y, Franganillo-Suárez A, Salgado-Sánchez R, et al. Spontaneous remission of acute myeloid leukemia: a case report. Medicina (Kaunas). 2022;58(7):921. doi:10.3390/medicina58070921
  77. Bülbül H, Nazlı HE, Olgun A, Togay A, Kahraman DS. Spontaneous remission of chronic lymphocytic leukemia in a patient with SARS-CoV-2. Leuk Res Rep. 2022;18:100336. doi:10.1016/j.lrr.2022.100336
  78. Barkhordar M, Rostami FT, Yaghmaie M, et al. Spontaneous complete remission of acute myeloid leukemia in the absence of disease-modifying therapy following severe pulmonary involvement by COVID-19. Case Rep Hematol. 2022;2022:2603607. doi:10.1155/2022/2603607
  79. Alshurafa A, Ekeibed Y, Akiki S, et al. Spontaneous remission in a patient with chronic myeloid leukemia: a case report. Case Rep Oncol. 2023;16(1):1073–1079. doi:10.1159/000533660
  80. Imataki O, Ishida T, Kida JI, et al. Repeated spontaneous remission of acute myeloid leukemia in response to various infections: a case report. BMC Infect Dis. 2023;23(1):215. doi:10.1186/s12879-023-08108-z
  81. McCormick BJ, Imran H. Spontaneous remission of acute lymphoblastic leukemia following Candida tropicalis fungemia. Cureus. 2024;16(6):e62435. doi:10.7759/cureus.62435
  82. Diral E, Catalano G, Cicinelli MV, et al. Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report. Front Oncol. 2024;14:1399894. doi:10.3389/fonc.2024.1399894
  83. Peñuela R, Hernandez I, Fernandes-Pineda M, et al. Spontaneous remission without treatment of acute myelomonocytic leukemia associated with COVID-19 infection. Hematol Transfus Cell Ther. 2024;46(4):506–510. doi:10.1016/j.htct.2023.11.004
  84. Higaki-Mori H, Yamada N, Ozaki K, Nishimura MF, Yoshida Y. Spontaneous complete regression of aleukaemic cutaneous myeloid sarcoma without progression to leukaemia over a long-term follow-up period. Acta Derm Venereol. 2025;105:adv42339. doi:10.2340/actadv.v105.42339
  85. Southam et al., 1951. A Study of the Natural History of Acute Leukemia with Special Reference to the Duration of the Disease and the Occurrence of Remissions. Cancer 4: 1951; 39-59
  86. Al-Tawfiq, J. A., & Al-Khatti, A. A. (2007). Spontaneous remission of acute monocytic leukemia after infection with clostridium septicum. International Journal of Laboratory Hematology, 29(5), 386-389. doi:10.1111/j.1365-2257.2006.00846.x Spontaneous remissions of acute myeloid leukemia (AML) have been reported in association with infection. Here, we report a case of spontaneous remission of AML in a 47-year-old Saudi Arabian male patient who presented with a few weeks history of recurrent abdominal pain, vomiting and fever. He was diagnosed with acute monocytic leukemia (AML, FAB M5b) and a perforated bowel. He also had Clostridium septicum bacteremia and thus chemotherapy was deferred. He received supportive therapy and intravenous antibiotics. Six weeks later, he achieved spontaneous and complete remission lasting for about 4 months. The remission and relapse were documented by bone marrow examination. Similarly, previous reports of spontaneous remission of AML were short lived and were followed by relapse and progression.
  87. Hudecek, M., BARTsch, K., Jäkel, N., Heyn, S., Pfannes, R., Al-Ali, H. K., Cross, M., Pönisch, W., Gerecke, U., Edelmann, J., Ittel, T., & Niederwieser, D. (2008). spontaneous remission of acute myeloid leukemia relapse after hematopoietic cell transplantation in a high-risk patient with 11q23/MLL abnormality. Acta haematologica, 119(2), 111–114. https://doi.org/10.1159/000121827
  88. Thomas, J., & Gaffney, J. K. (2007). spontaneous remission in Wegener's granulomatosis. Scandinavian journal of rheumatology, 36(4), 324–326. https://doi.org/10.1080/03009740701250769
  89. D’Arena, G., Guariglia, R., Pietrantuono, G., Villani, O., MARTorelli, M. C., Mansueto, G., … Musto, P. (2014). More on spontaneous regression of chronic lymphocytic leukemia: two new cases and potential role of lamivudine in a further patient with advanced disease and hepatitis B virus infection. Leukemia & Lymphoma, 55(8), 1955–1957. https://doi.org/10.3109/10428194.2013.858151
  90. Kaźmierczak, M., Szczepaniak, A., Czyż, A., Rupa-Matysek, J., & Komarnicki, M. (2014). spontaneous hematological remission of acute myeloid leukemia. Contemporary oncology (Poznan, Poland), 18(1), 67–69. https://doi.org/10.5114/wo.2013.38915
  91. Gyárfás, T., Wintgens, J., Biskup, W., Oschlies, I., Klapper, W., Sieberight, R., Bens, S., Haferlach, C., Meisel, R., Kuhlen, M., & Borkhardt, A. (2016). Transient spontaneous remission in congenital MLL-AF10 rearranged acute myeloid leukemia presenting with cardiorespiratory failure and meconium ileus. Molecular and cellular pediatrics, 3(1), 30. https://doi.org/10.1186/s40348-016-0061-7
  92. Gómez García, E. B., van Lochem, E. G., van Lom, K., & Hooijkaas, H. (2002). spontaneous remission of b-chronic lymphocytic leukaemia. British journal of haematology, 119(3), 874–875. https://doi.org/10.1046/j.1365-2141.2002.03870_1.x
  93. Müller-Schmah, C., Solari, L., Weis, R., Pfeifer, D., Scheibenbogen, C., Trepel, M., May, A. M., Engelhardt, R., & Lübberight, M. (2012). Immune response as a possible mechanism of long-lasting disease control in spontaneous remission of MLL/AF9-positive acute myeloid leukemia. Annals of hematology, 91(1), 27–32. https://doi.org/10.1007/s00277-011-1332-y
  94. Shichishima, T., Kawaguchi, M., Ono, N., Oshimi, K., Nakamura, N., & Maruyama, Y. (2004). Gammadelta T-cell large granular lymphocyte (LGL) leukemia with spontaneous remission. American journal of hematology, 75(3), 168–172. https://doi.org/10.1002/ajh.10480
  95. van den Berg, H., Hopman, A. H., Kraakman, K. C., & de Jong, D. (2004). spontaneous remission in congenital leukemia is not related to (mosaic) trisomy 21: case presentation and literature review. Pediatric hematology and oncology, 21(2), 135–144. https://doi.org/10.1080/08880010490273000
  96. Wajima T. (2000). spontaneous regression of chronic lymphocytic leukemia and simultaneous development of autoimmune hemolytic anemia and autoimmune thrombocytopenia. American journal of hematology, 65(1), 88–89. https://doi.org/10.1002/1096-8652(200009)65:1<88::aid-ajh20>3.0.co;2-q
  97. Helbig, D., Quesada, A. E., Xiao, W., Roshal, M., Tallman, M. S., & Knorr, D. A. (2020). Spontaneous Remission in a Patient With Acute Myeloid Leukemia Leading to Undetectable Minimal Residual Disease. Journal of hematology, 9(1-2), 18–22. https://doi.org/10.14740/jh606
  98. Raza et al., 1985. Spontaneous Remission in Acute Nonlymphocytic Leukemia. New York State Journal of Medicine 85(6): Jun 1985; 269-270
  99. Lancet 2(8357): Oct 29 1983; 1030
  100. Han, T. 1987. Spontaneous Remission of Chronic Lymphocytic Leukemia: An Update. Blood Cells 12(2): 1987; 481-483
  101. Hackett & Hallidie-Smith, 1984. Spontaneous Closure of Coronary Artery Fistula. British Heart Journal 52(4): Oct 1984; 477-479
  102. Chan et al., 1989. Spontaneous Resolution of Pulmonary Stenosis. International Journal of Cardiology 24: 1989; 375-377
  103. Labbe et al., 1983. Spontaneously Acquired Factor VIII Inhibitor in a Non-Haemophiliac Child. Acta Paediatrica Scandinavica 72: 1983; 621-623